Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhibitor

Objective: to investigate the impact of therapy with the interleukin-6 receptor inhibitor tocilizumab (TCZ) on the time course of changes in N-terminal pro-brain  natriuretic  peptide (NT-proBNP) levels in patients with rheumatoid arthritis (RA) during a 12-month follow-up period.Subjects and method...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	E. V. Gerasimova, T. V. Popkova, A. V. Martynova, M. V. Cherkasova, D. S. Novikova
פורמט:	Artigo
שפה:	Russo
יצא לאור:	IMA PRESS LLC 2019-11-01
סדרה:	Научно-практическая ревматология
נושאים:	nt-probnp rheumatoid arthritis chronic heart failure tocilizumab
גישה מקוונת:	https://rsp.mediar-press.net/rsp/article/view/2783
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!